Open session of the standing technical committee of the EUFMD- 2004

Page 158

Appendix 22 Molecular epidemiological studies of Foot-and-Mouth disease virus in sub-Saharan Africa indicate the presence of large numbers of topotypes: implications for local and international control Vosloo, W.1*, Dwarka, R.M.1, Bastos, A.D.S.2, Esterhuysen, J.J.1, Sahle, M.3, Sangare, O.4 1

Exotic Diseases Division, Onderstepoort Veterinary Institute, Private Bag X05, Onderstepoort, 0110, South Africa 2 Mammal Research Institute, Department of Zoology and Entomology, University of Pretoria, Pretoria 0002, South Africa 3 National Animal Health Research Centre, Ethiopia 4 Laboratoire Central Veterinaire, BP 2295, Bamako, Mali Abstract: Six of the seven serotypes of foot and mouth disease (FMD) virus occur on the African continent and numerous topotypes occur for each serotype. Due to underreporting of FMD, the current strains circulating throughout sub-Saharan Africa are in most cases not known. For both SAT-1 and SAT-2 the genetic diversity is reflected in antigenic variation and indications are that vaccine strains may be needed for each topotype. This has serious implications for control using vaccines and for choice of strains to include in international vaccine banks. The epidemiology of FMD is further complicated by the presence of large numbers of persistently infected African buffalo (Syncerus caffer) and other wildlife species which together with largely uncontrolled movement of domestic animals may spread the disease over vast distances. This dearth of knowledge on FMD in Africa poses a serious threat to regions free of FMD in the face of increased international travel and the possible smuggling of illegal bushmeat and other livestock products. Introduction: Foot and mouth disease (FMD) virus probably originated from Africa since greater genetic variation occurs in the SAT types (Vosloo et al., 1995; Bastos et al., 2000; Bastos, 2001; Bastos et al., 2001; Bastos et al., 2003a and b) and a sub-clinical cycle occurs in African buffalo (Syncerus caffer) where the virus can persist in a single animal for up to five years (Condy et al., 1985). This is the only species for which long-term maintenance of FMD virus has been described (Hedger, 1972; Hedger et al., 1972; Hedger, 1976; Condy et al., 1985; Thomson, 1994; Thomson et al., 2001; Thomson et al., 2003). During persistent infection in buffalo, the SAT type viruses undergo high rates of mutation, giving rise to genetic and antigenic variants (Vosloo et al., 1996). The disease is endemic to most countries in sub-Saharan Africa (Vosloo et al., 2002) and will not be eradicated from southern and East Africa while infected buffalo are present. Disease-free areas are recognised mainly in southern Africa, where a number of countries have been able to control FMD by separating infected buffalo from livestock and by limited use of vaccination (Brückner et al., 2002; Thomson et al., 2003). Lack of movement control within countries and across international borders for both wildlife and domestic animals aggravates the problem, and gives credence to the fact that FMD will remain a problem on the sub-continent for the foreseeable future. With the increase in international travel, the threat from illegally smuggled bushmeat and other livestock products cannot be ignored, and it is imperative to understand the current epidemiology of FMD to predict what strains are currently most likely to pose a threat to disease-free regions. Six of the seven serotypes of FMD virus occur on the African continent (Vosloo et al., 2002), with the exception of Asia-1, which complicates control of the disease by vaccination. In sub-Saharan Africa, two cycles of FMD occur, one where virus circulates between wildlife hosts and domestic animals and the other where the virus spreads among domestic animals, without the involvement of wildlife (Vosloo and Thomson, 2004). In southern Africa and to a large extent, eastern Africa, the cycle between wildlife and domestic animals occurs, while in West Africa, due to the low numbers of wildlife, the disease is maintained predominately in domestic animals. However, once disease crosses from wildlife into domestic animals, a domestic cycle could be maintained without the involvement of wildlife. As it is costly to sample wildlife, very little is known about the FMD virus populations circulating in these animals and most information outside southern Africa is based on isolates obtained from domestic animals. Molecular epidemiological studies have contributed in planning control strategies by elucidating historical and current disease transmission patterns within and between countries. Furthermore, it is 149


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Open session of the standing technical committee of the EUFMD- 2004 by EuFMD - Issuu